MIDDLE EAST PHARMACEUTICAL INDUSTRIES TADAWUL:4016:
AVALON PHARMA - BOARD'S RECOMMENDATION TO INCREASE CAPITAL BY GRANTING BOUNS SHARES
AVALON PHARMA - GRANTS THREE (3) BONUS SHARES FOR EVERY FOUR (4) SHARES HELD
Avalon Pharma Grants Three Bonus Shares For Every Four Shares Held
Middle East Pharmaceutical Industries Company on 6ix
Earlier from Middle East Pharmaceutical Industries
- Avalon Pharma Signs Non-Binding Memorandum Of Understanding With Benta Sas
- Avalon Pharma Q3 Profit SAR 8.28 Mln
- ZAWYA: Saudi's Avalon Pharma renews $14mln credit with Saudi Investment Bank
- Middle East Pharmaceutical Industries H2 Dividend Per Share SAR 1.25
Later from Middle East Pharmaceutical Industries
- Avalon Pharma Contract Sign Off With Bio-Thera Solutions
- Avalon Pharma FY Profit 97.01 Mln Riyals
- Avalon Pharma H2 Dividend Per Share SAR 1.32
- Avalon Pharma Appoints Ahmad Shaher Al Tabbaa As Chairman
- Avalon Pharma Q1 Profit SAR 26.9 Million
Follow Middle East Pharmaceutical Industries into a list and get an email when it puts out news.
Follow Middle East Pharmaceutical Industries